Personalised Medicine Development Area (DA) is focused on eliminating several bottlenecks that globally hinder the application of the achievements of molecular medicine and info- and communication technology (ICT) in the interests of human health. Therefore, we have set the general aims of personalised medicine DA as combining the recent key advances in medical and population genetics, bioinformatics, E-Health and ICT in general, to develop preventive, diagnostic and treatment algorithms and decision-support systems for personalised medicine for common complex diseases and cancer.